G 5 ASN 0 -2.338 -2.069 <=B
G 6 THR 0 -2.480 -2.195 <=B
G 7 ALA 0 -2.792 -2.471 <=B
G 8 SER 1 -2.744 -2.543 <=B
G 9 ILE 2 -3.183 -3.047 <=B
G 10 ALA 3 -3.222 -3.197 <=B
G 11 GLN 4 -2.818 -2.954 <=B
G 12 ALA 5 -3.304 -3.499 <=B
G 13 ARG 5 -2.840 -3.089 <=B
G 14 LYS 6 -2.521 -2.921 <=B
G 15 LEU 6 -2.704 -3.083 <=B
G 16 VAL 6 -2.471 -2.876 <=B
G 17 GLU 6 -1.754 -2.243 <=B
G 18 GLN 6 -1.743 -2.232 <=B
G 19 LEU 6 -2.106 -2.554 <=B
G 20 LYS 6 -1.310 -1.850 <=B
G 21 MET 6 -1.394 -1.923 <=B
G 22 GLU 6 -1.471 -1.992 <=B
G 23 ALA 6 -1.478 -1.998 <=B
G 24 ASN 6 0.062 -0.635 <=B
G 25 ILE 8 -1.389 -2.149 <=B
G 26 ASP 1 -1.662 -1.585 <=B
G 27 ARG 7 -2.618 -3.122 <=B
G 28 ILE 8 -4.115 -4.562
G 29 LYS 3 -4.763 -4.561
G 30 VAL 0 -6.064 -5.367
G 31 SER 0 -6.265 -5.544
G 32 LYS 4 -6.399 -6.123
G 33 ALA 5 -6.857 -6.643
G 34 ALA 3 -8.268 -7.662
G 35 ALA 5 -8.098 -7.742
G 36 ASP 6 -8.203 -7.950
G 37 LEU 6 -8.807 -8.484
G 38 MET 6 -8.690 -8.380
G 39 ALA 7 -8.440 -8.274
G 40 TYR 5 -8.668 -8.247
G 41 CYS 8 -8.993 -8.879
G 42 GLU 6 -8.362 -8.090
G 43 ALA 6 -7.494 -7.322
G 44 HIS 9 -7.071 -7.293
G 45 ALA 8 -6.622 -6.781
G 46 LYS 1 -4.876 -4.430
G 47 GLU 3 -4.011 -3.895
G 48 ASP 9 -4.881 -5.354
G 49 PRO 9 -2.257 -3.033 <=B
G 50 LEU 1 -3.131 -2.886 <=B
G 51 LEU 9 -5.195 -5.632
G 52 THR 8 -3.468 -3.989
G 53 PRO 4 -1.796 -2.050 <=B
G 54 VAL 13 -0.425 -1.871 <=B
G 55 PRO 2 0.539 0.247 <=B
G 56 ALA 3 1.676 1.138 <=B
G 57 SER 0 2.065 1.827 <=B
G 58 GLU 9 1.173 0.003 <=B
G 59 ASN 11 1.180 -0.221 <=B
G 60 PRO 2 2.415 1.907 <=B
G 61 PHE 4 1.910 1.230 <=B
G 62 ARG 8 2.021 0.869 <=B
G 63 GLU 7 2.579 1.477 <=B
G 64 LYS 0 2.497 2.210 <=B

Identified 37 B-Cell epitope residues out of 60 total residues